BLS FY2026 Results Announcement

Aug 30, 2026 at 10:37 PM EDT · Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX · Aug 30, 2026 at 10:37 PM EDT

On 6ix: 6ix.com/news/bls-fy2026-results-announcement

Suite 506, Level 5 50 Clarence Street, Sydney NSW 2000, Australia hello@breathelifesciences.com +61 2 9078 8180 BLS Pharmaceuticals Ltd | ASX:BLS | www.blspharma.com 1 31 August 2026 Record revenue and earnings as BLS scales international pharmaceutical...

View Attachment

6ix hasn’t read this filing yet.

BLS Pharmaceuticals Limited on 6ix

In the deck

BLS Pharmaceuticals — Investor Presentation (August 2026)24 slidesAug 31, 2026

Earlier from BLS Pharmaceuticals

Annual Report to shareholdersAug 30
BLS FY2026 Results Webinar 2 September 2026 8am AESTAug 26
Application for quotation of securities - BLSAug 12
BLS to Present at Coffee Microcaps 31/7/2026 at 11.30 amJul 30
BLS Pharmaceuticals Investor Webinar PresentationJul 29

Later from BLS Pharmaceuticals

BLS Investor PresentationAug 30
BLS FY2027 GuidanceAug 30
Appendix 4G Corporate Governance StatementAug 31
S&P DJI Announces September 2026 Quarterly RebalanceSep 4
Angus Walker Appointed Alternate Director to Edward MyerSep 13

All BLS Pharmaceuticals news releases

Follow BLS Pharmaceuticals into a list and get an email when it puts out news.

Follow BLS Pharmaceuticals